德琪医药-B：9月14日增发1009万股，已发行股本变动

公告速递09-14

德琪医药-B（股票代码：06996）于2026年9月14日在香港联交所刊发翌日披露报表，宣布因2022年受限制股份单位计划向董事及非董事授予股份奖励或期权并相应发行新股。本次共计增发1,240,000股及8,850,000股，发行价格均为每股0港元，分别占公司此次变动前已发行股份（不包括库藏股）总数的约0.183%和1.3064%。

增发完成后，德琪医药-B的已发行股份数量由677,417,632股增至687,507,632股，库藏股数额维持2,029,000股，合计股份总数为689,536,632股。公司确认已就此次发行事宜获得董事会正式授权，并严格遵守香港联交所证券上市规则及相关法律法规。公告由董事会主席梅建明博士签署。

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohunote.com/m/news/1110762610?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2026-09-14 19:06","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1110762610","market":"us","top_or_hot":-1,"title":"德琪医药-B：9月14日增发1009万股，已发行股本变动","media":"公告速递","content":"<p>德琪医药-B（股票代码：06996）于2026年9月14日在香港联交所刊发翌日披露报表，宣布因2022年受限制股份单位计划向董事及非董事授予股份奖励或期权并相应发行新股。本次共计增发1,240,000股及8,850,000股，发行价格均为每股0港元，分别占公司此次变动前已发行股份（不包括库藏股）总数的约0.183%和1.3064%。</p>\n<p>增发完成后，德琪医药-B的已发行股份数量由677,417,632股增至687,507,632股，库藏股数额维持2,029,000股，合计股份总数为689,536,632股。公司确认已就此次发行事宜获得董事会正式授权，并严格遵守香港联交所证券上市规则及相关法律法规。公告由董事会主席梅建明博士签署。</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>德琪医药-B：9月14日增发1009万股，已发行股本变动</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n德琪医药-B：9月14日增发1009万股，已发行股本变动\n</h2>\n\n<h4 class=\"meta\">\n\n2026-09-14 19:06 北京时间&nbsp;&nbsp;&nbsp;<strong>公告速递</strong>\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>德琪医药-B（股票代码：06996）于2026年9月14日在香港联交所刊发翌日披露报表，宣布因2022年受限制股份单位计划向董事及非董事授予股份奖励或期权并相应发行新股。本次共计增发1,240,000股及8,850,000股，发行价格均为每股0港元，分别占公司此次变动前已发行股份（不包括库藏股）总数的约0.183%和1.3064%。\n增发完成后，德琪医药-B的已发行股份数量由677,417,632...</p>\n\n<a href=\"\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06996","symbol_name":"德琪医药-B","start_time":0,"source_url":"","article_id":"1110762610","we_media_id":"1097772564","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1110762610","pubTimestamp":1789383996,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"公告速递","introduction":"港美股公告全覆盖","home_visible":1,"id":"1097772564","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"德琪医药-B于2026年9月14日在香港联交所刊发翌日披露报表，宣布因2022年受限制股份单位计划向董事及非董事授予股份奖励或期权并相应发行新股。本次共计增发1,240,000股及8,850,000股，发行价格均为每股0港元，分别占公司此次变动前已发行股份总数的约0.183%和1.3064%。增发完成后，德琪医药-B的已发行股份数量由677,417,632股增至687,507,632股，库藏股数额维持2,029,000股，合计股份总数为689,536,632股。","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"zh","relate_stocks":{"06996":"德琪医药-B"},"translate_title":"Deqi Pharmaceutical-B: 10.09 million new shares issued on September 14, representing a change in issued share capital.","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06996":1},"content_text":"德琪医药-B（股票代码：06996）于2026年9月14日在香港联交所刊发翌日披露报表，宣布因2022年受限制股份单位计划向董事及非董事授予股份奖励或期权并相应发行新股。本次共计增发1,240,000股及8,850,000股，发行价格均为每股0港元，分别占公司此次变动前已发行股份（不包括库藏股）总数的约0.183%和1.3064%。\n增发完成后，德琪医药-B的已发行股份数量由677,417,632股增至687,507,632股，库藏股数额维持2,029,000股，合计股份总数为689,536,632股。公司确认已就此次发行事宜获得董事会正式授权，并严格遵守香港联交所证券上市规则及相关法律法规。公告由董事会主席梅建明博士签署。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1110762610","isCrawlerRequest":true}